Dosage Forms Suitability in Pediatrics: Acceptability of Antibiotics in a German Hospital
-
Published:2023-12-07
Issue:12
Volume:12
Page:1709
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Klingmann Viviane1ORCID, Vallet Thibault2ORCID, Münch Juliane1ORCID, Wolters Lena1, Stegemann Robin1, Bosse Hans Martin1, Ruiz Fabrice2ORCID
Affiliation:
1. Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Children’s Hospital Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany 2. ClinSearch, 110 Avenue Pierre Brossolette, 92240 Malakoff, France
Abstract
Although drug acceptability can have a significant impact on patient adherence in pediatric therapy, data are limited, even for common therapeutic areas. We present the second part of an acceptability study conducted at the University Children’s Hospital Düsseldorf, Germany. The study investigated the acceptability of most commonly used antibiotics in a pediatric hospital setting. The researchers used the acceptability reference framework to score the acceptability of five antibiotics based on 150 real-life observer reports of medicine intake. Four antibiotics assessed in this study were formulated as preparations for injection (ampicillin, ampicillin/sulbactam, ceftriaxone, and gentamicin) and one as a powder for oral liquid suspension (co-amoxiclav). All the antibiotics formulated as preparations for injection were rated negatively due to high rates of negative reactions (80%), the use of restraint (51%), the use of extra devices (99%), and long preparation and administration times (100%). The antibiotic formulated as a powder was significantly more well accepted. The study concluded that there is a lack of appropriate formulations for antibiotics for use in children. These findings are important in improving knowledge on acceptability drivers and might help in formulating and prescribing better medicines for children. The study highlights the need for healthcare professionals to have knowledge about the acceptability of different products to select the best-adapted product for each patient.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference30 articles.
1. EMA (2013). Guideline on Pharmaceutical Development of Medicines for Paediatric Use, European Medicines Agency (EMA) CfMPfHU. 2. EMA (2007). The European Paediatric Initiative: History of the Paediatric Regulation, EMA. 3. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial;Klingmann;J. Pediatr.,2018 4. Acceptability of Small-Sized Oblong tablets in Comparison to Syrup and Mini-tablets in Infants and Toddlers: A Randomized Controlled Trial;Meissner;Eur. J. Pharm. Biopharm.,2021 5. Vallet, T., Bensouda, Y., Saito, J., Mathiesen, L., Pokharkar, V., Klingmann, V., Peak, M., Elhamdaoui, O., Yamatani, A., and Ivanovic, I. (2021). Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study. Pharmaceutics, 13.
|
|